Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

New anticoagulant drugs.

Weitz JI, Hirsh J.

Chest. 2001 Jan;119(1 Suppl):95S-107S. Review. No abstract available.

PMID:
11157644
2.

Ancrod: understanding the agent.

Illig KA, Ouriel K.

Semin Vasc Surg. 1996 Dec;9(4):303-14. Review. No abstract available.

PMID:
8958607
3.

Approaches in anticoagulation: rationales for target positioning.

Wieland HA, Laux V, Kozian D, Lorenz M.

Curr Opin Investig Drugs. 2003 Mar;4(3):264-71. Review.

PMID:
12735227
4.

Ancrod: clinical indications and methods of use.

Wright JG, Geroulakos G.

Semin Vasc Surg. 1996 Dec;9(4):315-28. Review. No abstract available.

PMID:
8958608
5.

The new anticoagulants: new opportunities, new issues.

Vlasuk GP.

Arch Pathol Lab Med. 1998 Sep;122(9):812-4. Review. No abstract available.

PMID:
9740140
6.

[Basic principles anticoagulant therapy].

Mammen EF.

Internist (Berl). 1969 Jan;10(1):2-8. Review. German. No abstract available.

PMID:
4190310
7.

New anticoagulants: an update.

Crowther M, Weitz JI.

Clin Adv Hematol Oncol. 2004 Nov;2(11):743-9. Review.

PMID:
16170892
8.

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.

Hirsh J, Anand SS, Halperin JL, Fuster V; American Heart Association.

Circulation. 2001 Jun 19;103(24):2994-3018. Review. No abstract available.

9.

Anticoagulants and thrombolytics: what's the difference?

Workman ML.

AACN Clin Issues Crit Care Nurs. 1994 Feb;5(1):26-35. Review.

PMID:
7767794
10.

New anticoagulant drugs: monitoring and perioperative strategies.

Ickx BE.

Acta Anaesthesiol Belg. 2006;57(4):409-18. Review.

PMID:
17236644
11.

Low molecular weight heparins. A pharmacologic overview.

Hillis LB.

Adv Nurse Pract. 1997 Oct;5(10):53-6. Review. No abstract available.

PMID:
9459986
12.

Oral factor Xa and direct thrombin inhibitors: a clinical perspective.

Thethi I, Lewis B, Fareed J.

J Burn Care Res. 2012 Jul-Aug;33(4):453-61. doi: 10.1097/BCR.0b013e318248bc4c. Review.

PMID:
22269826
13.

Overview of anticoagulant drugs for the future.

Moll S, Roberts HR.

Semin Hematol. 2002 Jul;39(3):145-57. Review.

PMID:
12124677
14.

[New anticoagulants].

Levi M, Peters RJ, Piek JJ, Büller HR.

Ned Tijdschr Geneeskd. 2003 May 10;147(19):909-15. Review. Dutch.

PMID:
12768805
15.

[ANTICOAGULANTS TODAY].

Bokarev IN.

Klin Med (Mosk). 2016;94(1):5-9. Review. Russian.

PMID:
27172714
16.

[Relation between the hemostatic process and thrombosis. A clinical problem].

Ponari O, Dettori AG.

Recenti Prog Med. 1968 Sep;45(3):259-82. Review. Italian. No abstract available.

PMID:
4916345
17.

Recent advances in marine algal anticoagulants.

Matsubara K.

Curr Med Chem Cardiovasc Hematol Agents. 2004 Jan;2(1):13-9. Review.

PMID:
15320802
18.

Hirudin and derivatives as anticoagulant agents.

Markwardt F.

Thromb Haemost. 1991 Jul 12;66(1):141-52. Review. No abstract available.

PMID:
1926044
19.

Short- and long-acting synthetic pentasaccharides.

Koopman MM, Büller HR.

J Intern Med. 2003 Oct;254(4):335-42. Review.

20.

Editors' Choice papers in Thrombosis and Haemostasis.

Weber C, Lip GY.

Thromb Haemost. 2015 Jan;113(1):217-20. Review. No abstract available.

PMID:
25567474

Supplemental Content

Support Center